PT3901141T - Nova forma de isoquinolinossulfonamida - Google Patents
Nova forma de isoquinolinossulfonamidaInfo
- Publication number
- PT3901141T PT3901141T PT198990541T PT19899054T PT3901141T PT 3901141 T PT3901141 T PT 3901141T PT 198990541 T PT198990541 T PT 198990541T PT 19899054 T PT19899054 T PT 19899054T PT 3901141 T PT3901141 T PT 3901141T
- Authority
- PT
- Portugal
- Prior art keywords
- isoquinolinesulfonamide
- novel form
- novel
- Prior art date
Links
- GZZCYMXZJQCAJU-UHFFFAOYSA-N isoquinoline-1-sulfonamide Chemical compound C1=CC=C2C(S(=O)(=O)N)=NC=CC2=C1 GZZCYMXZJQCAJU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018235213 | 2018-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3901141T true PT3901141T (pt) | 2024-03-04 |
Family
ID=71101331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT198990541T PT3901141T (pt) | 2018-12-17 | 2019-12-16 | Nova forma de isoquinolinossulfonamida |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11427546B2 (pt) |
| EP (1) | EP3901141B1 (pt) |
| JP (1) | JP7425482B2 (pt) |
| KR (1) | KR20210104729A (pt) |
| CN (1) | CN113195453B (pt) |
| AU (1) | AU2019402422A1 (pt) |
| BR (1) | BR112021011739A2 (pt) |
| CA (1) | CA3120751A1 (pt) |
| DK (1) | DK3901141T3 (pt) |
| EA (1) | EA202191339A1 (pt) |
| FI (1) | FI3901141T3 (pt) |
| MX (1) | MX2021007233A (pt) |
| PT (1) | PT3901141T (pt) |
| SG (1) | SG11202105739YA (pt) |
| WO (1) | WO2020129876A1 (pt) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1370914A (en) | 1971-07-06 | 1974-10-16 | Ici Ltd | Paint compositions |
| DE3943678C2 (de) * | 1988-12-26 | 1999-11-25 | Hiroyoshi Hidaka | Isochinolinsulfonsäureamide, Verfahren zu deren Herstellung und diese Amide enthaltende pharmazeutische Zusammensetzung |
| US5340811A (en) | 1990-03-08 | 1994-08-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same |
| JP2899953B2 (ja) | 1995-07-03 | 1999-06-02 | 旭化成工業株式会社 | １−（５−イソキノリンスルホニル）ホモピペラジン塩酸塩１／２水和物 |
| ES2142065T3 (es) | 1995-07-03 | 2000-04-01 | Asahi Chemical Ind | Clorhidratos de 1-(5-isoquinoleinsulfonil)homopiperazina hidratado. |
| MY139797A (en) * | 2004-11-29 | 2009-10-30 | Kowa Co | (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate |
| ES2396795T3 (es) | 2007-07-02 | 2013-02-27 | Asahi Kasei Pharma Corporation | Compuesto de sulfonamida y cirstal del mismo |
| KR101911324B1 (ko) | 2010-12-22 | 2018-10-25 | 가부시키가이샤 디. 웨스턴 세라퓨틱스 겡큐쇼 | 신규한 치환 이소퀴놀린 유도체 |
| JP5819705B2 (ja) | 2011-11-09 | 2015-11-24 | 興和株式会社 | イソキノリン誘導体塩酸塩無水物結晶 |
-
2019
- 2019-12-16 DK DK19899054.1T patent/DK3901141T3/da active
- 2019-12-16 PT PT198990541T patent/PT3901141T/pt unknown
- 2019-12-16 WO PCT/JP2019/049099 patent/WO2020129876A1/ja unknown
- 2019-12-16 EP EP19899054.1A patent/EP3901141B1/en active Active
- 2019-12-16 MX MX2021007233A patent/MX2021007233A/es unknown
- 2019-12-16 CA CA3120751A patent/CA3120751A1/en active Pending
- 2019-12-16 JP JP2020561396A patent/JP7425482B2/ja active Active
- 2019-12-16 US US17/296,439 patent/US11427546B2/en active Active
- 2019-12-16 FI FIEP19899054.1T patent/FI3901141T3/fi active
- 2019-12-16 KR KR1020217019115A patent/KR20210104729A/ko unknown
- 2019-12-16 EA EA202191339A patent/EA202191339A1/ru unknown
- 2019-12-16 SG SG11202105739YA patent/SG11202105739YA/en unknown
- 2019-12-16 AU AU2019402422A patent/AU2019402422A1/en active Pending
- 2019-12-16 CN CN201980082942.XA patent/CN113195453B/zh active Active
- 2019-12-16 BR BR112021011739-3A patent/BR112021011739A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7425482B2 (ja) | 2024-01-31 |
| FI3901141T3 (fi) | 2024-03-01 |
| EP3901141B1 (en) | 2024-02-07 |
| US11427546B2 (en) | 2022-08-30 |
| EA202191339A1 (ru) | 2021-08-27 |
| EP3901141A1 (en) | 2021-10-27 |
| CN113195453A (zh) | 2021-07-30 |
| JPWO2020129876A1 (ja) | 2021-11-04 |
| EP3901141A4 (en) | 2022-07-13 |
| US20220017469A1 (en) | 2022-01-20 |
| WO2020129876A1 (ja) | 2020-06-25 |
| CN113195453B (zh) | 2024-04-30 |
| CA3120751A1 (en) | 2020-06-25 |
| BR112021011739A2 (pt) | 2021-08-31 |
| MX2021007233A (es) | 2021-07-15 |
| AU2019402422A8 (en) | 2021-07-01 |
| SG11202105739YA (en) | 2021-07-29 |
| AU2019402422A1 (en) | 2021-06-17 |
| DK3901141T3 (da) | 2024-02-26 |
| KR20210104729A (ko) | 2021-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272888B1 (en) | Uses of piperidinyl-indole derivatives | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| SG10202111790YA (en) | Synthesis of omecamtiv mecarbil | |
| IL268731A (en) | New uses of anti-SIRPG antibodies | |
| ZA202003267B (en) | Novel combinations of defoliants | |
| IL274627A (en) | Solid state form of valbenazine | |
| IL272697A (en) | A polymorphic form of TG02 | |
| GB201806072D0 (en) | Methods of manufacture | |
| EP3894768C0 (en) | METHOD FOR CRYOHARDENING | |
| IL276592A (en) | History of Subtirum | |
| SG11202005711TA (en) | Novel uses | |
| IL272857A (en) | Cofanalisib formulations | |
| GB201805904D0 (en) | Methods of Manufacture | |
| IL282396A (en) | new uses | |
| IL270961A (en) | Crystalline form of N-butyldeoxygalactonogirimycin | |
| GB2575067B (en) | Selection of identifiers | |
| ZA202105399B (en) | Use of spiropidion | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| SG11202105136WA (en) | Application of chidamide | |
| GB201919180D0 (en) | New composition of matter | |
| PT3901141T (pt) | Nova forma de isoquinolinossulfonamida | |
| PL3511335T3 (pl) | Wytwarzanie metalosilseskwioksanów | |
| IL283421A (en) | Solid state forms of reproxalap | |
| GB201910666D0 (en) | Novel form of compounds | |
| GB201910665D0 (en) | Novel form of compounds |